Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Articulation time does not affect speeded cognitive performance in multiple sclerosis.
Concurrent acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
P wave duration and dispersion and QT interval in multiple sclerosis.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Anesthesia for the obstetric patient with multiple sclerosis.
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
Validating archetypes for the Multiple Sclerosis Functional Composite.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
Adapted exercise interventions for persons with progressive multiple sclerosis.
Optic neuritis and the evaluation of visual impairment in multiple sclerosis.
Immune surveillance and response to JC virus infection and PML.
Discovery of novel disease-specific and membrane-associated markers in a mouse model of multiple sclerosis.
Chronic illness and return to work: a social cognitive perspective.
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.
Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey.
Quantifying progression of multiple sclerosis via classification of depth videos.
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Multiple sclerosis: Activation of cortical microglia linked to level of disability in patients with multiple sclerosis.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis.
Pages
« first
‹ previous
…
422
423
424
425
426
427
428
429
430
…
next ›
last »